5 Oversold Penny Stocks To Buy

4. Theseus Pharmaceuticals, Inc. (NASDAQ:THRX)

Number of Hedge Fund Holders: 16

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) has lost about 36% in value year to date through August 8. This penny stock is in the oversold territory due to its low RSI value. However, 16 hedge funds in Insider Monkey’s database of funds reported owning stakes in Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) as of the end of the first quarter.

However, Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) investors got a setback in July after the company announced to end the development of its lead asset THE-630 for gastrointestinal stromal tumors.

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) will now focus on THE-349, an EGFR inhibitor for EGFR mutant non-small cell lung cancer. The biggest stakeholder of Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) was Samuel Isaly’s OrbiMed Advisors which had a $153 million stake in the company.